C-Reactive Protein is a Risk Indicator for Atrial Fibrillation After Myocardial Revascularization
Authors:
- Bernard LoBLBernard Lo
- Rob FijnheerRFRob Fijnheer
- Arno P. NierichANArno P. Nierich
- Peter BruinsPBPeter Bruins
- Cor J. KalkmanCKCor J. Kalkman
- 1 May 2005
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 79 (5) , 1530-1535
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
This publication has 28 references indexed in Scilit:
- Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillationEuropean Heart Journal, 2004
- Inflammation as a Risk Factor for Atrial FibrillationCirculation, 2003
- Competing autonomic mechanisms precedethe onset of postoperative atrial fibrillationJACC, 2003
- The −174G/C Interleukin-6 Polymorphism Influences Postoperative Interleukin-6 Levels and Postoperative Atrial Fibrillation. Is Atrial Fibrillation an Inflammatory Complication?Circulation, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cellsImmunology Today, 1997
- THE SURGICAL MANAGEMENT OF ATRIAL FIBRILLATIONAnnual Review of Medicine, 1997
- The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypassEuropean Journal of Cardio-Thoracic Surgery, 1991
- Interaction of C-reactive protein with artificial phosphatidylcholine bilayersNature, 1979